4D Pharma PLC (LBPS) Stock Analyst Ratings
NASDAQ:LBPS - Nasdaq - US35085K1097 - ADR
ChartMill assigns a Buy % Consensus number of 80% to LBPS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.52. This target is 356.04% above the current price.
LBPS was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about LBPS.
In the previous month the buy percentage consensus was at a similar level.
LBPS was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-06-27 | Chardan Capital | Downgrade | Buy -> Neutral |